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ABSTRACT: The 19-transmembrane γ-secretase complex gener-
ates the amyloid β-peptide of Alzheimer’s disease by intramembrane
proteolysis of the β-amyloid precursor protein. This complex is
comprised of presenilin, Aph1, nicastrin, and Pen-2. The exact
function and mechanism of the highly conserved Pen-2 subunit
remain poorly understood. Using systematic mutagenesis, we
conﬁrm and extend our understanding of which key regions and
speciﬁc residues play roles in various aspects of γ-secretase function,
including maturation, localization, and activity, but not processivity.
In general, mutations (1) within the ﬁrst half of transmembrane
domain (TMD) 1 of Pen-2 decreased PS1 endoproteolysis and
γ-secretase proteolytic activity, (2) within the second half of TMD1
increased proteolytic activity, (3) within the cytosolic loop region decreased proteolytic activity, (4) within TMD2 decreased PS1
endoproteolysis, (5) within the ﬁrst half of TMD2 decreased proteolytic activity, and (6) within C-terminal residues decreased
proteolytic activity. Speciﬁc mutational eﬀects included N33A in TMD1 causing an increase in γ-secretase complexes at the
cell surface and a modest decrease in stability and the previously unreported I53A mutation in the loop region reducing stability
10-fold and proteolytic activity by half. In addition, we conﬁrm that minor PS1 endoproteolysis can occur in the complete
absence of Pen-2. Together, these data suggest that rather than solely being a catalyst for γ-secretase endoproteolysis, Pen-2 may
also stabilize the complex prior to PS1 endoproteolysis, allowing time for full assembly and proper traﬃcking.
γ-Secretase is a 19-transmembrane domain (TMD), intra-
membrane aspartyl protease comprised of presenilin (PS1 or
PS2 isoform) as the catalytic component,1 along with nicastrin
(Nct), anterior pharynx defective-1 (Aph1αL, Aph1αS, or
Aph1β isoform), and presenilin enhancer-2 (Pen-2). All four
components are necessary and suﬃcient for γ-activity.2−4 The
γ-secretase complex is responsible for the second and ﬁnal step
in regulated intramembrane proteolysis (RIP)5 of a large and
increasing number of substrates, the most studied of which are
the β-amyloid precursor protein (APP) and Notch.6 A further
complexity of γ-secretase function is the fact that cleavage
of the membrane-anchored C99 stub of APP (as a model
γ-substrate) occurs at multiple sequential peptide bonds,
starting with ε-cleavage to release the APP intracellular domain
(AICD) from the membrane and leave a 49- or 48-residue
amyloid β-protein (Aβ) peptide.7,8 Sequential cleavages of
Aβ48/49 every three or four residues moving N-terminally (i.e.,
every helical turn of the TMD) occur ﬁrst at the so-called ζ-site
to produce Aβ45/46, then at the γ-site to produce Aβ42/43, and
ﬁnally at the γ′-site to produce Aβ38/40 peptides.9 Aβ42 is
generally considered the most pathogenic (i.e., self-aggregating)
Aβ species, with an elevated Aβ42/Aβ40 ratio used as a marker
of pathogenicity,10 although recently, Aβ43 has also been shown
to be pathogenically relevant in vivo.11 The sequential C-terminal
trimming of the initial ε-cleavage products Aβ48 and Aβ49 by
γ-secretase is termed processivity.12
Biochemical studies have previously shown that the Pen-2
subunit is the ﬁnal component added to γ-secretase,4 where-
upon the PS holoprotein undergoes autoproteolysis1,13 in a
hydrophobic domain within the cytosolic loop between TMD 6
and 7 to form stable N-terminal and C-terminal fragments
(NTF and CTF, respectively) that stay associated in the
membrane as heterodimers.14 The essential nature of Pen-2 was
illustrated in vivo using Pen-2 knockout mice,15 the embryonic
lethal phenotype of which was very similar to that of a PS1/PS2
double knockout or a Notch1 knockout. Pen-2 is very highly
conserved, being invariably 101 residues long with 70% identity
and 87% similarity among all vertebrates and retaining 56%
similarity between Homo sapiens and Arabidopsis thaliana
(Figure 1a,b). Glycosylation studies were utilized to demon-
strate that the topology of Pen-2 comprises lumenal N- and
C-termini, two TMDs, and a cytosolic loop region.16 The ﬁrst
of these two TMDs was previously reported to be important for
interaction with TMD 4 of PS117,18 and was more recently
localized to a water-accessible pore.15 The cytosolic loop region
of Pen-2 is apparently accessible from the lumenal side of
membranes via a hydrophilic cavity and may interact with
PS1-CTF.15
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In addition to facilitating PS endoproteolysis, Pen-2 can play
other roles. The C-terminal region may be important for γ-
secretase complex stability.19 An endoplasmic retention signal
sequence in TMD1 may be critical for traﬃcking.20 Pen-2 is
required for γ-secretase complex maturation in a manner
independent of PS1 endoproteolysis as shown by a lack of Nct
glycosylation in PS1ΔExon9 cells.21 The N-terminal region
may aﬀect substrate processivity.22 Adding to the complexity of
this protein’s function are two recent reports, one showing that
puriﬁed PS1 holoprotein can undergo endoproteolysis upon
addition of puriﬁed Pen-2 alone without a need for Aph1 or
Nct23 and the second using Pen-2 knockdown to propose that
PS1 can undergo endoproteolysis without Pen-2.24 Because of
these multiple putative functions and little knowledge of the
mechanisms by which this subunit acts upon γ-secretase, we
have used a Pen-2 knockout cell line15 to conduct an extensive
mutagenesis screen to investigate Pen-2 cell localization, Pen-2
stability, γ-secretase activity, and γ-secretase maturation.
■ EXPERIMENTAL PROCEDURES
DNA Constructs. All Pen-2 mutants were generated using
the QuikChange Lightning Site-Directed Mutagenesis kit
(Agilent Technologies) with primers designed by PrimerX
(http://www.bioinformatics.org/primerx) and purchased from
Life Technologies. The FLAG-Pen-2 template in pcDNA3.1(+)-
Hygromycin was used as described previously.2 C99 substrate
came from a cDNA comprising the human APP signal sequence
followed by the 99 C-terminal residues of human APP in pCAG
(gift of T. Young-Pearse at the Center for Neurologic Diseases).
Cell Lines and Transfection. Pen-2 knockout mouse
embryonic ﬁbroblasts were a kind gift of B. De Strooper (KU
Leuven, Leuven, Belgium). Cells were transfected using the 4D-
Nucleofector X unit and P3 Primary Cell 4D-Nucleofector
X kit (Lonza), recovered in RPMI medium with 10% FBS for
15 min, and then plated in 60 mm dishes with 4 mL of DMEM
and 10% FBS. Six hours after the cells had been plated, media
Figure 1. Sequence conservation of Pen-2. (a) Multiple-sequence alignment of forms of Pen-2 from various model organisms. The black bar denotes
the predicted transmembrane domains. Sequence conservation between Animalia or Vertebrata is shown with asterisks for identical residues, colons
for highly similar residues and periods for similar residues. (b) Details of sequence identity and similarity. (c) Cartoon of Pen-2 within the lipid
membrane. (d) Human Pen-2 sequence including the N-terminal FLAG tag with residues mutated to alanine or other residues colored gray. Putative
transmembrane domains are underlined.
Biochemistry Article
dx.doi.org/10.1021/bi500489j | Biochemistry 2014, 53, 4393−44064394
were replaced with fresh DMEM and 10% FBS. Conditioned
media were harvested after 18 h and stored at −80 °C. Cells
were lysed in 1% CHAPSO, 50 mM HEPES (pH 7.2), 150 mM
NaCl, and complete protease inhibitors (Roche). For each
experiment, a set of several Pen-2 mutants was paired with wild-
type Pen-2, and the same cell suspension was aliquoted and
transiently transfected with each.
Western Blotting, Enzyme-Linked Immunosorbent
Assays (ELISAs), and Antibodies. Western blot analyses
were performed by electrophoreses of cell lysates on 4 to 12%
Bis/Tris polyacrylamide gels, and the samples were transferred
to polyvinylidene diﬂuoride membranes and probed with the
antibodies anti-human nicastrin (1:1000; BD Transduction
Laboratories), anti-PS1-NTF (B19, kind gift of B. De
Strooper), anti-PS1-CTF (1:2000; Abcam 76083), anti-Pen-2
(1:5000; Abcam 154830), anti-GAPDH (Novus Biologicals
221), anti-calnexin (1:2000; Abcam 22595), or anti-Aβ
(Calbiochem 6E10). All Western blots were scanned on an
Odyssey Infrared Imaging System (Li-Cor), and densitometry
analysis used Odyssey software. Aβ40 and Aβ42 from conditioned
media were measured by triplex ELISA (Aβ capture by antibody
4G8) read on a Sector Imager 2400 (Mesoscale Discovery).
Cell Surface Biotinylation. Surface proteins were labeled
using sulfo-NHS-SS-biotin (Thermo Scientiﬁc 21331) follow-
ing the manufacturer’s protocol. In brief, cells were grown to
conﬂuence and then washed gently four times with ice-cold
PBS before the addition of 0.5 mg/mL sulfo-NHS-SS-biotin in
PBS and incubation with shaking at room temperature for
30 min. Cross-linking was quenched by addition of Tris buﬀer
(pH 8) to a ﬁnal concentration of 50 mM and shaking for
10 min. Cells were washed four times with ice-cold PBS, then
detached by being scraped in 25 mM EDTA in PBS buﬀer
(pH 8), and pelleted at 16000g for 3 min at 4 °C. Cell pellets
were lysed in 1% CHAPSO, 50 mM HEPES (pH 7.2), 150 mM
NaCl, and protease inhibitor cocktail (Roche) on ice for 1 h.
Lysates were clariﬁed by centrifugation at 21000g for 5 min and
protein concentrations determined by the BCA assay (Thermo
Scientiﬁc). Equal protein amounts were pulled down by mixing
with streptavidin agarose in 0.2% CHAPSO and0.08% digitonin
in TBS at 4 °C overnight. Unbound materials were removed,
and resins were washed three times with ice-cold 0.1% digitonin
in TBS before elution with Laemmli sample buﬀer and heating
to 65 °C for 5 min. Eluates and protein-normalized start lysates
were subjected to 4 to 12% Bis/Tris sodium dodecyl sulfate−
polyacrylamide gel electrophoresis (SDS−PAGE) for Western
blotting.
Pen-2 Stability Assay. To measure Pen-2 and γ-secretase
complex stability, fresh medium was added, and then cells were
treated with a ﬁnal concentration of 10 μM MG132 or an
equivalent volume of DMSO vehicle as a negative control at 37 °C
in 5% CO2 for 8 h. Cells were harvested and lysed as in the cell
surface biotinylation experiments, and then equal protein amounts
were resolved via SDS−PAGE for Western blotting. β-Catenin was
used as a positive control to demonstrate proteasomal inhibition.25
Immunoprecipitation (IP) Activity Assay. IP activity
assays were performed by immobilizing γ-secretase using anti-
nicastrin (Sigma N1660) bound to protein A agarose at 4 °C
for 1.5 h, followed by three washes with 0.25% CHAPSO,
50 mM HEPES buﬀer (pH 7.2), and 150 mM NaCl. Resin was
resuspended in 50 μL of 1 mg/mL phosphatidylcholine,
0.25 mg/mL phosphatidylethanolamine, 0.25% CHAPSO [in
50 mM HEPES buﬀer (pH 7.2) and 150 mM NaCl], and 1 μM
C100-FLAG substrate26 and incubated at 37 °C for 3 h. Bound
samples were eluted with Laemmli sample buﬀer for analysis by
SDS−PAGE and Western blotting, including resolution of
various Aβ species on bicine/urea gels.9,12 Quantiﬁcation of
bicine/urea Western blots was performed using ImageJ.
Microsome Preparation. Microsomes were prepared as
described previously27 with the addition of 10 μM pepstatin A
or vehicle (ethanol) at all stages of preparation.
Statistics. Statistical analysis of transient transfection
Western blot densitometry and ELISA data were performed
by the Harvard NeuroDiscovery Center’s Biostatistics Con-
sultation core. We ﬁt mixed-eﬀects models for the log of the
ratio of Aβ40 from mutant Pen-2 to Aβ40 from wild-type Pen-2.
This method included ﬁxed eﬀects for mutant Pen-2 and
random eﬀects for a date within a given mutant (to adjust for
multiple samples for some mutants on some dates) and for a
set within a date (to adjust for a particular wild-type sample).
We apply a Bonferroni correction for the multiple testing due
to the 39 mutants and use a p value threshold of 0.05/39 =
0.001. Each mutant was tested on at least three independent
occasions (n = 1−3 on each day) grouped with diﬀerent mutants
and compared to an internal wild-type control (n = 3−9).
Statistical analysis of stable cell line experiments was performed
using a one-way analysis of variance with Bonferonni correction to
account for multiple comparisons with the wild-type control using
GraphPad Prism. Cell surface biotinylation experimental data are
the means of four independent experiments each with an n value
of 1−3 (total n = 5−7).
■ RESULTS
Given the remarkable sequence conservation of the Pen-2
subunit of γ-secretase and its reported requirement for the
maturation and catalytic activity of the complex, speciﬁc changes
in the sequence may lead to alteration of speciﬁc functions. To
test this hypothesis, key residues were mutated within Pen-2
(Figure 1d), and these mutant constructs were then expressed
transiently to attempt to rescue a Pen-2 knockout mouse
embryonic ﬁbroblast (Pen-2 KO) line.15 Eﬀects of these mutants
on complex maturation were analyzed by Western blot of cell
lysates and densitometry. Proteolytic activities of the Pen-2
mutant-containing γ-complexes were examined by cotransfection
of the transfected Pen-2 KO cells with human wild-type APP and
subsequent ELISA analysis of Aβ.
Residues were chosen for mutation on the basis of a high
degree of sequence conservation, the type of amino acid, and
the location within the sequence. For example, the N-terminally
clustered charged residues (E9, E10, and K11) were
individually mutated to alanine. C15 was mutated to alanine
and also to the more conservative serine to remove the thiol
but minimally alter the polarity and size of the side chain.
Conserved aromatic amino acids (particularly tryptophan and
tyrosine) have aﬃnity for the lipid polar headgroups and so can
be largely found at the lipid−water interface important in
deﬁning the TMD boundaries.28 Therefore, the conserved
amino acids Y18, Y19, W36, F37, F38, and Y56 were each
mutated to alanine to potentially disrupt the anchoring of
TMDs to the lipid bilayer. Finally, P27 is located in the center
of TMD1, and it would be predicted to induce a 30° bend in
the helix.29 Mutating this residue to alanine would remove this
helix break and might potentially cause signiﬁcant alterations in
the incorporation and function of Pen-2 within γ-secretase.
The Substrate Concentration Is Critical upon Co-
transfection of Pen-2 KO MEFs with C99 and Pen-2.
Pen-2 KO MEFs15 could be rescued with an N-terminally
Biochemistry Article
dx.doi.org/10.1021/bi500489j | Biochemistry 2014, 53, 4393−44064395
FLAG-tagged wild-type (wt) Pen-2 (F-Pen-2), leading to
complex maturation as shown by PS1 endoproteolysis (to NTF
and CTF) and Nct maturation (further glycosylation) (Figure 2a).
It should be noted that the addition of the FLAG tag retards
migration of Pen-2 relative to the endogenous Pen-2 seen in MEFs
from wt littermates (Figure 2a, left lane).
Before examining the eﬀects of Pen-2 mutations on complex
assembly, maturation, and activity, we sought to identify the
factors needed for rescue of the Pen-2 KO cells and detection
of substrate cleavage activity. With regard to γ-secretase activity,
the level of secretion of Aβ from Pen-2 KO cells rescued
with wt F-Pen-2 was tested. Because of a very low level of
endogenous expression of mouse APP in the cells, it was not
possible to detect any Aβ in conditioned media (data not
shown). However, transfection of C99 with the APP signal
sequence gave robust Aβ40 and Aβ42 secretion upon rescue with
wt F-Pen-2. As a negative control, cells were also transfected
with C99 in the absence of Pen-2 rescue and gave undetectable
levels of Aβ by an ELISA (data not shown).
To determine whether variability of substrate or active
γ-secretase complexes could be tolerated for our analysis, Pen-2
KO cells were ﬁrst transfected with a standard amount (1.5 μg)
of wt F-Pen-2 DNA and increasing amounts of C99 DNA.
Equal expression levels of the γ-secretase components were
seen regardless of the level of co-expressed C99 substrate
(Figure 2b; because of cytotoxicity, the ﬁnal two lanes have
smaller amounts of total protein loaded). Normalization of Aβ
in the conditioned media to total cellular protein revealed a
stepwise increase in Aβ40 and Aβ42 production with an
increasing level of C99 DNA (Figure 2c). Aβ42/40 ratios were
consistently ∼0.11−0.12 across all amounts of C99 DNA
transfected (Figure 2d), a value that is squarely in the physio-
logical range. In the reverse experiment, Pen-2 KO MEFs were
then transfected with equal (0.5 μg) amounts of C99 DNA and
increasing amounts of wt F-Pen-2 DNA (Figure 2e), which
revealed a stepwise increase in expression levels of F-Pen-2
(Figure 2f) and, as expected, of PS1-CTF (Figure 2g) as a
measure of complex maturation. Figure 2h shows the ratio of
PS1-CTF per unit of F-Pen-2, which is unchanging as the level of
F-Pen-2 DNA increases. This relative uniformity is very
important for the setup of all of our experiments (below), as it
is likely that diﬀerent mutants of Pen-2 may express to diﬀerent
degrees. Finally, we again see the expected stepwise increase in
the level of Aβ secretion with an increase in the level of wt
F-Pen-2 DNA (Figure 2i), but when normalized to PS1-CTF
(i.e., Aβ per mature γ-secretase complex) levels of substrate
cleavage do not vary (Figure 2j). Together, these experimental
validation data inform us that it is essential for C99 expression
levels to be equal between samples within a set of transfections,
while a variable level of Pen-2 expression will not aﬀect the
analysis when normalizing to PS1-CTF.
To account for experiment-to-experiment variation in the
expression levels of our diﬀerent Pen-2 mutants (Figure 3b),
internal controls were included to allow proper normalization.
Each set of mutant F-Pen-2 transfections being performed on a
given day also included one to three simultaneous wt F-Pen-2
Figure 2. Validation of the Pen-2 KO MEF cell line. (a) Western blot comparing various components of γ-secretase in Pen-2 KO MEF cells with and
without rescue using F-Pen-2, and MEF cells from wild-type littermates. (b) Western blot of Pen-2 KO cells rescued with 1.5 μg of F-Pen-2 and
cotransfected with increasing quantities of C99 DNA. CHO S20 cells, overexpressing all four γ-secretase components, treated with DAPT act as a
control for C99 accumulation. (c) Secretion of Aβ from cells measured by an ELISA and normalized to the total cell lysate. (d) Ratio of Aβ42/40
based on ELISA data. (e) Western blot of Pen-2 KO cells rescued with increasing quantities of F-Pen-2 DNA and cotransfected with 0.5 μg of C99
DNA. (f) Densitometry of F-Pen-2 expression levels. (g) Densitometry of PS1-CTF levels. (h) Levels of PS1-CTF per unit of F-Pen-2. Levels of
Aβ40 per (i) milligram of cell lysate and (j) unit of PS1-CTF. Error bars show the standard error from three replicates. *P < 0.05. **P < 0.01.
***P < 0.001.
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control transfections. Values calculated within that experimental
set were ﬁrst normalized to total protein in the cell lysate and
then expressed as a percentage of the mean wt F-Pen-2 value. Each
data point shown is the mean of at least three independent
experiments of one to three replicates, each normalized to their
respective wt F-Pen-2 controls. To avoid data artifacts, the
groupings of speciﬁc mutants transfected in a given experiment
were varied between days.
Pen-2 Mutants Rescue γ-Secretase Complex Matura-
tion to Varying Degrees. Unexpectedly, all of the Pen-2
mutants screened were able to at least partially rescue PS1
endoproteolysis. In the N-terminal region, E4R, E9A, L12A,
L14A, R16A, and K17A all gave increases in the PS1-CTF:Pen-2
ratio relative to wt Pen-2 (Figure 3a). However, this may be
misleading, as total Pen-2 levels (i.e., γ-secretase-incorporated
plus free) of those mutants were all below that of the wild type
(Figure 3b), suggesting that rather than increasing the level of
endoproteolysis, they reduce the stability of Pen-2, thus raising
the relative ratio of PS1-CTF to Pen-2. In other words,
transfection with these mutants leads to a degradation of
unincorporated Pen-2 quicker than that with the wild type. In
the case of C15S, a similar reduction in the total level of Pen-2
did not lead to an increase but rather a decrease in the level of
PS1 endoproteolysis (Figure 3a), suggesting that this mutation
is ineﬃcient at supporting complex maturation. Most mutations
within TMD1 led to a reduction in the total level of Pen-2, with
W30A in particular at a level <20% of that of the wild type
(Figure 3b). This is likely due to its decreased level of
incorporation into γ-secretase, as shown by a reduced level of
PS1 endoproteolysis (Figure 3a). Mutations within the loop
region generally reduced Pen-2 levels, with the exception of
I53A, which had highly variable but somewhat elevated levels
(Figure 3b). Of all mutants we tested, I53A caused the largest
decrease in the level of PS1 endoproteolysis per Pen-2 unit,
suggesting this site is particularly important in PS1
endoproteolysis (Figure 3a) because of either a weakened
ability to allow endoproteolysis or a reduced aﬃnity for γ-
secretase. This question is addressed using stable cell lines,
covered later in this study (Figures 7−9). Mutations in TMD2
almost all gave a large increase in total Pen-2 levels (Figure 3b)
and in some cases a reduction in the level of PS1 endoproteolysis
per Pen-2 (Figure 3a), suggesting an increase in the stability of
unincorporated Pen-2. The same eﬀect is found in the C-terminal
region F94A mutation, while mutation of D90 to remove (>A) or
reverse (>R) this negative charge substantially reduced the total
level of Pen-2 (Figure 3b) and increased PS1-CTF:Pen-2 ratios
(Figure 3a).
Pen-2 Mutants Have Varying Eﬀects on γ-Secretase
Cleavage of the Substrate. Via measurement of Aβ in media
conditioned by Pen-2 KO cells cotransfected with C99 and
mutant F-Pen-2 and normalization to PS1-CTF level (i.e.,
amount of Aβ produced per mature γ-secretase complex), the
eﬀect of mutations on substrate cleavage by γ-secretase can be
determined. Surprisingly, several of the mutant Pen-2-containing γ-
secretase complexes actually cleaved more substrate than wild-type
Pen-2 complexes, while more than one-third caused a reduction in
cleavage. Within the N-terminal region, the largest eﬀects on
γ-secretase cleavage activity were found with loss of the polar N8
residue, which increased Aβ40 to nearly 300% and Aβ42 to 180% of
that of wt, and the L14A mutation, which increased Aβ40 to
Figure 3. Pen-2 mutants rescue PS1 endoproteolysis to varying degrees. (a) Band intensity of PS1-CTF per unit of F-Pen-2 normalized to internal
controls of wild-type human F-Pen-2. Colors denote the values above and below the wild-type value. (b) Band intensity of F-Pen-2 mutants
normalized to internal controls of wild-type human F-Pen-2. Colors denote the values above and below the wild-type value. The schematic below
each graph aligns the regions of Pen-2 being mutated. Error bars show the standard error from 3−10 independent experiments. *P < 0.05. **P <
0.01. ***P < 0.001.
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∼160% and Aβ42 to >200% of that of wt (Figure 4a,b). The C15A
mutation reduced both Aβ40 and Aβ42 to approximately 50%;
however, the C15S mutation produced no change (Figure 4a,b).
Mutation of either of the N-terminal positively charged (lysine)
residues (K11 and K17) to alanine caused an increase in Aβ40
(Figure 4a) and in the case of K17 also increased Aβ42 (Figure 4b).
All mutations within the top (N-terminal) half of TMD1 led to
reduced Aβ40 and Aβ42 secretion, with the greatest eﬀect from the
bulky hydrophobic residues F25 and L26 (30−50% of that of wt)
and a less pronounced eﬀect in the cases of the two lipid−water
interface aromatic residues Y18 and Y19 (70% of that of wt)
(Figure 4a,b). Mutations in the lower (C-terminal) half of TMD1
had the opposite eﬀect and elevated Aβ production, with the
exception of the aromatic hydrogen bonding-capable W36,
mutation of which lowered Aβ production. Interestingly, loss
of the immediately adjacent aromatic hydrophobic F37 caused
>2-fold increases in the production of both Aβ40 and Aβ42
(Figure 4a,b). Substantially enhanced cleavage was also caused
by mutation of either the positively charged N33 or aromatic
hydrophobic W30 to alanine (Figure 4a,b). Within the loop
region, mutations I53A, V57A, and in particular K54A reduced
Aβ40 secretion (Figure 4a). However, Aβ42 was very signiﬁ-
cantly increased in the case of I53A, while again the other
mutants reduced cleavage (Figure 4b). Mutation of residues in
TMD2 had relatively modest eﬀects, with G63A/Y67A causing
a slight decrease in both Aβ40 and Aβ42 and F78A causing a
slight increase (Figure 4a,b). In the C-terminal region, a loss of
the negatively charged D90 caused both Aβ40 and Aβ42 to
increase to approximately 160% of that of wt, while reversing
the charge to a positive arginine reduced secretion of both Aβ
species to approximately half (Figure 4a,b). Finally, a loss of the
hydrophobic F94 led to a reduction in Aβ production to 40% of
that of wt (Figure 4a,b).
Eﬀects on Aβ42/40 Ratios. Of all the mutations tested, only
a few had any eﬀect on Aβ42/40 ratios, and those were relatively
subtle. The one exception to this was with mutation of the
hydrophobic I53, which caused a slight decrease in Aβ40 and a
>4-fold increase in Aβ42, thus leading to a doubling of the
Aβ42/40 ratio (Figure 5). Other mutants causing a decrease in
the ratio of Aβ species were mostly clustered in the lower half
of TMD1 (i.e., including and right after the helix-breaking P27)
but also occurred at the N-terminal region (E4R and N8A),
upper TMD2 (S73A and W74A), and C-terminal D90A
(Figure 5). The only other sites of mutation leading to elevated
Aβ42/40 were two leucine residues (L14A and L26A) and a
serine (S60A) (Figure 5).
Establishing Stable Cell Lines for Selected Mutants.
To further test the eﬀect of some of the most interesting
mutants of Pen-2, stable cell lines were established by stable
transfection of Pen-2 KO MEF cells with wild-type, N8A,
P27A, N33A, or I53A FLAG-Pen-2, with isolation of
monoclonal cell lines. These lines were then screened for
Pen-2 expression, and where possible, equally expressing lines
were selected (Figure 6a,c). Levels of PS1-CTF generation per
Pen-2 (Figure 6d) were similar to those observed in the
transient transfections for N8A having little eﬀect and P27A
some reduction, while I53A decreased endoproteolysis but
not as signiﬁcantly. N33A caused a modest decrease in the
PS1-CTF:Pen-2 ratio in the transient transfection experiments,
but the stable line displayed elevated endoproteolysis (Figure 6d).
However, upon IP via the FLAG tag of Pen-2, N8A, P27A, and
N33A all displayed unaltered levels of γ-secretase maturation
relative to that of wt Pen-2, but I53A showed <40% wt levels of
Figure 4. γ-Secretase activity levels per mature complex. (a) Aβ40 or (b) Aβ42 concentrations in conditioned media per unit of PS1-CTF normalized
to internal controls of wt human F-Pen-2. Colors denote the values above and below the wild-type value. The schematic below each graph aligns the
regions of Pen-2 being mutated. Error bars show the standard error from 3−10 independent experiments. *P < 0.05. **P < 0.01. ***P < 0.001.
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PS1-CTF associated with Pen-2, suggesting an impaired
complex stability (Figure 6b,e). Diﬀerences between transient
transfections and stable cell lines data observed are likely due to
the diﬀerent mechanisms of expression in those two systems.
The stable line has a more continuous but weaker expression,
allowing an equilibrium of γ-complex incorporation and cell
localization to be reached, while transient transfection by
electroporation leads to an immediate high expression that may
not be fully processed by cell machinery before the point of cell
lysis. This is particularly apparent in the case of I53A, which in
the transient system had an apparent expression level approx-
imately equal to that of wt (Figure 3b), while in the stable line, the
value was <40% of wt (Figure 6c), in turn associating with 30%
(Figure 3a) or 80% (Figure 6d) of wt PS1-CTF:Pen-2 levels. This
temporary saturation of protein degradation machinery may also
account for the discrepancy in the Aβ42/40 ratio between transient
and stable transfections with I53A Pen-2. In the transient system,
I53A Pen-2 complexes may be able to initiate substrate cleavage
but dissociate before full processing. N33A also showed a disparity
between the transient and stable transfections for γ-secretase
endoproteolysis, with the stable line having nearly 140% of the wt
level in mature complexes per Pen-2 (Figure 6d) and the transient
70% (Figure 3a), but both with equal expression levels (Figures 3b
and 6c). This may be due to the N33A complexes in the stable line
having increased cell surface localization, which may be expected
to elevate levels of the mature complex.
Asn33 Is Involved in Pen-2 Localization within the
Cell. To examine the eﬀect of certain mutations on the
transport of Pen-2 and γ-secretase to the cell surface, where
they are known to be active, we used the non-membrane
permeable sulfo-NHS-SS-biotin to speciﬁcally label plasma
membrane proteins via primary amines (i.e., lysine). The
biotinylated proteins could then be speciﬁcally isolated from a
total cell lysate using streptavidin agarose and then released by
cleavage of the biotin−amine cross-link with β-mercaptoetha-
nol. However, Pen-2 contains only two extracellular/lumenal
lysine residues (one of which forms the upper boundary of
TMD1 and may not be fully accessible for cross-linking), so
isolation of Pen-2 in NP40/RIPA buﬀer was very limited. This
diﬃculty was overcome by lysing the cells in 1% CHAPSO/
HEPES buﬀer and then pulling them down and washing them
in 0.1% digitonin/HEPES buﬀer. Both of these detergents, in
contrast with NP40, keep γ-secretase intact, allowing streptavidin
pull-down via all biotinylated lysines in the intact γ-secretase
complex. Digitonin is used for the binding and washing steps, as
it removes weakly or nonspeciﬁcally interacting proteins. In these
experiments, wild-type Pen-2 and its mutants could all be found
at the cell surface in association with γ-secretase (Figure 7a).
Surprisingly, PS1 holoprotein in the nonrescued Pen-2 KO line
could also be biotinylated (data not shown), thus requiring
conﬁrmation that the biotinylation reagent had not passed the
cell membrane by probing for the cytosolic protein GAPDH
(Figure 7a). As a secondary control protein, the ER-associated
transmembrane protein calnexin was also probed for; a small
amount could be detected in the biotinylated/streptavidin
Figure 5. Eﬀect of Pen-2 mutations on Aβ42/40 ratios. The Aβ42/40 ratio in conditioned media normalized to internal controls of wt human F-Pen-2.
Colors denote the values above and below the wild-type value. The schematic below each graph aligns the regions of Pen-2 being mutated. Error bars
show the standard error from 3−10 independent experiments. *P < 0.05. **P < 0.01. ***P < 0.001.
Figure 6. Stable cell lines of select Pen-2 mutants. Western blot of (a)
total cell lysate (input) and (b) FLAG IP (M2 IP) of exogenous F-
Pen-2 from monoclonal cell lines expressing wt, N8A, P27A, N33A, or
I53A F-Pen-2. (c) Densitometric analysis of Pen-2 expression levels in
each cell line normalized to internal controls of wild-type human F-
Pen-2. (d) Band intensity of PS1-CTF per unit of F-Pen-2 normalized
to internal controls of wild-type human F-Pen-2. (e) Band intensity of
PS1-CTF per unit of F-Pen-2 immunoprecipitated via FLAG tag
normalized to internal controls of wild-type human F-Pen-2. Error bars
show the standard error from three independent experiments *P <
0.05. **P < 0.01. ***P < 0.001.
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pull-down sample (17 ± 0.5-fold lower than the input lysate
calnexin level), suggesting that up to 6% of our biotinylated
sample could be from inside the cell (Figure 7a). This small
amount of biotinylated calnexin could mean that the biotinylated
PS1 holoprotein observed is not at the cell surface, rather in the
endoplasmic reticulum within the cell. Measuring the ratio of cell
surface mutant Pen-2 to that found in the lysate input and then
normalizing to the ratio for wild-type Pen-2 revealed that among
the four mutants we studied in stable cell lines, only N33A
showed a signiﬁcant increase in the proportion of cell surface
Pen-2 to total cellular Pen-2 (Figure 7b; P < 0.05). Interestingly,
this was not accompanied by an increase in PS1-CTF/Pen-2
(Figure 7c), as might be expected if more cell surface N33A
Pen-2 is in mature γ-secretase.
Ile53Ala and to a Lesser Extent Asn33Ala Reduce the
Stability of Pen-2. During the process of generating stable
cell lines for some Pen-2 mutants, we noted that all clones of
I53A had Pen-2 expression markedly lower than that of wild-
type lines. Two possible reasons for this observation are (1)
I53A Pen-2 is poorly expressed and (2) I53A Pen-2 has
reduced aﬃnity for PS1 and is targeted to the proteasome for
degradation. We tested the second explanation by inhibiting the
proteasome via treatment with MG132 (Figure 8a). β-Catenin,
known to be degraded rapidly by the proteasome, served as a
positive control. We found that wild-type Pen-2 and its four
mutants rose to >200% of untreated levels after MG132
treatment, with N33A and I53A increasing signiﬁcantly more
than wild type to 365 and almost 1000%, respectively (P <
0.001) (Figure 8b). PS1-CTF levels increased correspondingly
for wild-type and P27A, while N8A had an even greater
elevation (P < 0.05), resulting in a small but signiﬁcant increase
in the PS1-CTF:Pen-2 ratio (P < 0.01). MG132 treatment of
the N33A line did not signiﬁcantly increase PS1-CTF, and
there was therefore a slight decrease in its PS1-CTF:Pen-2 ratio
(P < 0.01). MG132 treatment of the I53A line caused PS1-CTF
to increase by 400%, but because of the accompanying very
large increase in Pen-2 levels, there was a very signiﬁcant
reduction in the PS1-CTF:Pen-2 ratio to 50% of that observed
in wild-type cells treated with MG132 (P < 0.001). These data
show that the I53A mutation does not aﬀect expression of Pen-
2 but greatly reduces its stability because of enhanced proteasomal
degradation. This MG132 treatment of the I53A line did not fully
rescue the endoproteolysis of PS1, suggesting that this mutation
may be aﬀecting Pen-2 by reducing incorporation into and
maturation and/or stability of γ-secretase.
Mutating Pen-2 Does Not Aﬀect γ-Secretase Proc-
essivity. Given the striking increase in the Aβ42/40 ratio upon
transient transfection of the I53A mutant into cells (Figure 5),
an in vitro γ-secretase activity assay was used to cleave
recombinant C100-FLAG, as is commonly used in cell-free
γ-secretase assays.26,30 Lysates of our stable cell lines were
Figure 7. Eﬀect of Pen-2 mutation on cell localization. (a) Western
blot of 10 μg of total cell lysate (Input) and 90 μg of cell surface
proteins pulled down with streptavidin agarose (Bound) for Pen-2 KO
MEF cells rescued with mutants of Pen-2 and labeled with non-
membrane permeable biotin. (b) Quantiﬁcation of Pen-2 mutant levels
at the cell surface compared to that of wild-type Pen-2. (c) Level of
PS1-CTF per Pen-2 at the cell surface compared to that of wild-type
Pen-2. Error bars show the standard error from three independent
experiments. *P < 0.05. **P < 0.01. ***P < 0.001.
Figure 8. Eﬀect of Pen-2 mutations on stability. (a) Western blot of total cell lysates for Pen-2 KO MEF cells rescued with mutants of Pen-2 and
treated with 10 μM MG132 or vehicle for 8 h. (b) Quantiﬁcation of PS1-CTF and Pen-2 mutant levels and the amount of PS1-CTF per Pen-2 after
MG132 treatment compared to that of a vehicle-treated sample. Bar colors denote wild-type and the four mutants tested. Error bars show the
standard error from three replicates. *P < 0.05. **P < 0.01. ***P < 0.001.
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immunoprecipitated with anti-Nct antibodies, and on-bead
activity assays were performed. γ-Secretase IP’ed from wt Pen-2
and all four mutant lines was able to cleave the C100-FLAG
substrate, generating AICD-FLAG (Figure 9a); however, three
mutants (P27A, N33A, and I53A) showed reduced activity
upon normalization for Pen-2 levels (Figure 9c). The resultant
Aβ peptides were then separated by bicine/urea polyacrylamide
electrophoresis and detected by Western blotting (Figure 9b) and
quantiﬁed by densitometry (Figure 9d). None of the mutants
showed a signiﬁcant diﬀerence from wt in the proﬁle of Aβ peptides
generated, suggesting that Pen-2 has no direct role in processivity.
PS1 Endoproteolysis Is Possible in the Absence of
Pen-2. Over the course of the MG132 treatment experiments,
we often noted what appeared to be background levels of PS1-
CTF (Figure 8a) and PS1-NTF (not shown) in the Pen-2 KO
MEFs. Treatment of Pen-2 KO cells with 10 μM MG132 and
harvesting at various time intervals revealed that PS1-CTFs
accumulated over time (Figure 10a), albeit only to ∼8% of
wild-type MEF levels at the last time point [9 h (Figure 10b)].
To conﬁrm that this observation is directly due to
autoproteolysis of PS1 by the aspartic acid dyad, microsomes
of Pen-2 KO cells were prepared in the presence of the aspartyl
protease inhibitor pepstatin A (a known inhibitor of PS1 auto-
proteolysis31) or vehicle at all stages. In the absence of pepstatin
A, accumulation of PS1-CTF and PS1-NTF was observed, with a
trace amount visible in the presence of inhibitor (Figure 10c).
This endoproteolytic event occurred during the ﬁrst step of cell
lysis by homogenization but is not observed upon chemical lysis
(data not shown). This result would suggest that the buﬀer
condition (pH 6 MES buﬀer) and the membranes being in a
vesicular form (no detergent) permit endoproteolysis, and protease
inhibitors prevent degradation of the subsequent tripartite complex.
Using immunoprecipitation of tripartite complexes via antibodies to
Nct or PS1-CTF, it was possible to enrich the PS1 heterodimer
from MG132-treated cell lysates and Pen-2 KO microsomes, but
there was no detectable on-bead activity that could be measured by
an AICD-FLAGWestern blot or an Aβ40 ELISA (data not shown).
■ DISCUSSION
Using a Pen-2 knockout mouse embryonic ﬁbroblast cell line15
rescued with Pen-2 constructs containing single missense
mutations, we show that Pen-2 is intimately linked with both γ-
secretase maturation and activity. Diﬀerent regions and even
individual amino acids within Pen-2 appear to have speciﬁc and
important functions (summarized in Figure 11).
As the presenilin subunit of γ-secretase contains the catalytic
aspartic acid residues and is the only subunit known to have
familial Alzheimer’s disease mutations, many studies have focused
on this component. For example, using cysteine scanning
approaches,32−35 regions on several PS1 transmembrane domains
have been identiﬁed to form part of a water-accessible pore, which
is presumably the locus in which substrate hydrolysis occurs. It has
even been proposed that PS1 can cleave the substrate in the
absence of the three other γ-secretase components,23 albeit at
extremely low levels.
Considerable information is also available about nicastrin,
partly because as the only γ-subunit with a large ectodomain, it
may play a role in the recognition of the lumenal end of a substrate
or its access to the complex. The E333 residue of Nct has been
reported to be required for γ-complex maturation36 and possibly
even activity.37 On the other hand, some studies have suggested
that Nct may be dispensable for γ-secretase activity.38,39
The other two components of γ-secretase have been rather
less studied, with Aph1 suggested to act as a scaﬀold and thereby
regulate assembly40 and play a role in substrate docking,41 and the
Pen-2 subunit being necessary for PS endoproteolysis and
subsequent stabilization of the mature, active complex.4,19
Because of the high level of sequence identity of Pen-2
between diﬀerent species and its invariable length of 101 amino
acids, we systematically mutated numerous residues within
diﬀerent regions of the protein and examined the eﬀect on
γ-secretase maturation and activity. Surprisingly, none of the
mutants tested completely abrogated either complex matura-
tion (i.e., PS endoproteolysis) or activity. This result is in
agreement with a scanning cysteine mutagenesis study.15 This
lack of complete loss of function in the two studies may relate
to mutating only single residues rather than clusters. For
example, mutation of D90YLSF to pentaalanine prevented the
association of Pen-2 with other components of γ-secretase and
hence PS1 endoproteolysis.42 Similarly, mutation of four
nonadjacent residues near the C-terminus to alanine caused
complex maturation to be completely halted.19 However, when
we tested a cluster mutation of N8EE>AAA, PS1 endoproteol-
ysis appeared unaﬀected while Aβ production per γ-secretase
complex was elevated approximately 3-fold above that of wild-
type Pen-2 (data not shown). These results indicate that
diﬀerent regions of Pen-2 have diﬀerent roles in γ-secretase
function.
Figure 9. Eﬀect of Pen-2 mutations on γ-secretase processivity. (a)
Western blot of total cell lysate (Input) and IP activity assay (Activity)
for Pen-2 KO MEF cells rescued with mutants of Pen-2. (b) Bicine/
urea Western blot of IP activity assay supernatants. (c) Activity per
mature γ-secretase complex calculated by densitometry of AICD-F/
PS1-CTF. (d) Quantiﬁcation of Aβ40, Aβ(42+43), and Aβ45+ displayed as
a percentage of total Aβ in lane. Error bars show the standard error from
two independent experiments. *P < 0.05. **P < 0.01. ***P < 0.001.
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With the exceptions of E10A, K11A, and W36A mutations,
mutation of most residues in the N-terminal region and in
TMD1 reduced Pen-2 expression. Altering the amino acid
sequence in this region could change the initial fold and entry
of TMD1 into the membrane, which in turn may cause the
protein to be targeted to the proteasome for degradation. In the
case of W30A, where a dramatic (20% of the wt level) loss of
expression was seen, the loss of a bulky hydrophobic residue in
the center of the transmembrane domain appears to be
detrimental. Interestingly, the K11A mutant has approximately
170% of wt expression levels, which could mean this is a normal
ubiquitination site (despite being on the lumenal side of the
membrane). Bergman et al.43 reported that mutation of the sole
cytosolic lysine residue, K54, to R did not prevent ubiquitination
of Pen-2. These authors also assessed a Pen-2 with all three lysines
mutated to arginine, but the protein could not be expressed. Here,
we found that K54A and K17A mutations had little eﬀect on Pen-
2 expression. This result would leave K11 as a candidate for the
ubiquitination target, although we cannot exclude ubiquitination of
non-lysine sites such as serine/threonine.44,45 In this regard, we
obtained 170% of wt Pen-2 levels with the S60A mutant. Similar
increases in Pen-2 levels were also found with most mutations in
TMD2, suggesting a previously unrecognized role of TMD2 in the
stability of Pen-2.
Mutation of several residues in the N-terminal region, especially
N8A and L14A, also caused an elevation in substrate cleavage. This
could be due to loss of an interaction with a lumenal region of PS1,
thus altering active site conformation, or the fact that these residues
normally block the entry of the substrate into the active site.
In addition to their reducing Pen-2 levels, almost all mutants
in TMD1 (from Y19 to N33) produced a decrease in PS1-CTF
per Pen-2 to 50−70% of the wt value. This agrees with a prior
report that the upper two-thirds of TMD1 is necessary for PS1
endoproteolysis.18 Two independent reports used domain
swapping of TMDs within PS1 to narrow the Pen-2 binding
site to a W203NF motif in the center of PS1 TMD4.17,46
Mutations in the upper half of Pen-2 TMD1 may be partly
deﬁcient in their ability to initiate endoproteolysis because of a
change in the conformation of the active site in PS1. Following
the same line of reasoning, without exception all mutants tested
in TMD1 above P27 caused a reduction in Aβ generated per
mature γ-secretase complex to 55−70% of wt levels.
Mutation of most residues from P27 to the end of TMD1
elevated substrate cleavage, producing 140−230% of the wt
level of Aβ40 and Aβ42 and in some cases a modest decrease in
the Aβ42/40 ratio. These substitutions on Pen-2 all replace a
large side chain with the small methyl group of alanine, perhaps
allowing PS1 to expand into a more open conformation
previously shown to lead to a relative decrease in Aβ42
47 and an
increase in substrate access to the active site. The exception in
this region was the W36A mutant, which led to a 50% level in
both Aβ species, possibly due to a change in the anchoring of
the bottom of TMD1 with the lipid−water interface and
thereby allowing F37/38 to form part of the transmembrane
domain. Mutation of F37 to alanine had the opposite eﬀect,
raising Aβ secretion to >200% compared to the wt value.
Our mutations in TMD2 mostly decreased the PS1-CTF:Pen-2
ratio, primarily because of increases in Pen-2. This may represent
excess free Pen-2 resulting from deﬁcient degradation of the
mutants, perhaps due to their altered cellular localization. In this
regard, N33 in TMD1 of Pen-2 was found to be targeted by the
ER retention protein Rer1,20 and a report that the WNF motif in
PS1 TMD4 is also a Rer1 binding site48 led to the proposal of a
masking of ER retention signals upon binding of Pen-2 to PS1
concealed both their Rer1 binding sites, allowing γ-secretase to
move to the Golgi apparatus. Our cell surface labeling experiments
indeed conﬁrm that N33 is involved in preventing Pen-2 from
moving to the plasma membrane. However, we saw an equal
increase in PS1-CTF at the cell surface of the N33A Pen-2 cells,
implying proper localization of the mature complex rather than
mislocalization of free Pen-2, thus arguing against the masking
hypothesis. A possible explanation for this discrepancy could be
that as we detected trace amounts of the ER-associated protein
calnexin, we may have inadvertently also labeled some PS1-CTF
within the cell, thus masking a potential slightly lower level of
PS1-CTF at the cell surface, which would then argue for N33A
Pen-2 shifting to the plasma membrane independently of the rest
of the γ-secretase complex. Mutation of residues in the lower half
of TMD2 may decrease Aβ production by altering the initial fold
of this TMD, thus changing the alignment of the rest of the TMD.
No other mutations we made in TMD2 aﬀected substrate
cleavage, and given its somewhat lower level of sequence
conservation, this domain may simply be required to position
the C-terminal domain relative to the rest of Pen-2.
Figure 10. PS1 can undergo endoproteolysis in the absence of Pen-2. (a) Western blot and (b) quantiﬁcation showing a time course of Pen-2 KO
MEF cell treatment with 10 μM MG132 or vehicle. (c) Western blot of microsomes prepared from Pen-2 KO MEF cells in the absence or presence
of 10 μM pepstatin A. The left two lanes contained lysates of Pen-2 KO rescued with F-Pen-2 or without rescue.
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As with TMD2, mutations in the C-terminus led to changes
in PS1-CTF/Pen-2 that seemed to correlate with Pen-2
expression levels. This appears to be at odds with a report
that point mutations to alanine within the C-terminus had no
eﬀect on Pen-2 expression or PS1 endoproteolysis, although
simultaneous mutation of all four fully conserved residues
(D90, F94, P97, and G99) decreased the stability of the γ-
complex.19 This apparent discrepancy may relate to their use of
stable Pen-2 shRNA expression, so that some endogenous Pen-
2 and corresponding low-level PS1 endoproteolysis remain (vs
full knockout of Pen-2 here). Another diﬀerence is that the
study by Prokop et al. used stable cell lines for each mutant,
while we used transient transfections. Although a previous
report42 found that mutation of some residues within the
D90YLSF motif of Pen-2 to alanine decreased Aβ production
during Pen-2 knockdown rescue, we found the opposite eﬀect
with D90A, a 70% increase in Aβ. This diﬀerence is likely to be
due to our calculating Aβ production per mature γ-secretase
complex, while the study by Hasegawa et al. showed raw Aβ per
milligram of protein values despite a level of PS1-NTF clearly
lower than that with wild-type Pen-2. Interestingly, when D90
is changed conservatively to E, a near-wild-type level of PS1
endoproteolysis occurs but Aβ generation is still reduced, albeit
less than with the D90A mutant. We also found that reversing
the charge (D90R) halved γ-activity. Mutation of the highly
conserved F94 to alanine caused a signiﬁcant decrease in Aβ
production.
Finally, we found two sites of particular interest in the
cytosolic loop region. K54A had no eﬀect on expression or
endoproteolysis, as previously shown by Bammens et al.,15 but
did cause reductions to 40 and 50% of wt levels for Aβ40 and
Aβ42, respectively. When stably expressed, the adjacent I53A
mutation showed a reduction in stability but was still able to
partially support endoproteolysis, which could be further
rescued by inhibition of the proteasome. However, the increase
in endoproteolysis was substantially smaller than would be
Figure 11. Eﬀect of mutation of diﬀerent regions of Pen-2. Cartoon summarizing the eﬀect of mutation of regions of the Pen-2 subunit on γ-
secretase PS1 endoproteolysis, substrate cleavage, complex stability, and cell localization.
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expected if corresponding directly to Pen-2 levels, indicating that
the I53A Pen-2 γ-complexes have reduced stability. In addition to
the reduced complex stability, each intact complex also displayed a
50% level of substrate cleavage in vitro. Together, these novel data
indicate that this isoleucine residue is very important for the overall
stability and function of γ-secretase. This ﬁnding leads us to
hypothesize that the cytosolic loop region of Pen-2 may be directly
and critically interacting with PS1. Given the location of this region
and the previous reports of Pen-2 TMD1 to PS1 TMD417,46 and
TMD2 binding to PS1-CTF,15 a possible candidate for Pen-2 I53
binding is to the conserved hydrophobic domain VII (HDVII) of
the large loop region of PS1. The short Pen-2 loop region could
then bring the large PS1 cytosolic loop closer to the catalytic core,
allowing subsequent autoproteolysis.
During the proteasome inhibition experiments, we observed
a faint signal for PS1-NTF/CTF in plain Pen-2 KO cell lysates.
This curious observation was also reported by Mao et al.,24
although they used Pen-2 siRNA, which may leave trace levels
of Pen-2. Thus, our experiments in Pen-2 knockout cells now
conﬁrm the report by Mao et al. We ﬁnd that endoproteolysis
appears to be facilitated under mildly acidic conditions that
coincide with the pH found in the Golgi network,49 the initial
site of γ-secretase complex maturation31 and the ﬁrst site of
detectable APP cleavage.50 It is still possible that this cleavage is
occurring due to another protease, but given that it can be
inhibited by pepstatin A, this would speciﬁcally necessitate an
aspartyl protease capable of cleaving at or very close to the
endoproteolytic site of γ-secretase, which would seem to be an
unlikely combination. Ahn et al. previously reported that PS1
ΔE9 is able to cleave the substrate in the absence of any other
γ-secretase subunits.23 Using both Pen-2 KO microsomes and
Pen-2 KO MG132-treated lysate IPs, we detected no substrate
cleavage measured by an AICD-FLAG Western blot or an Aβ40
ELISA. By comparing PS1-CTF band intensity for wt Pen-2
(Figure 9a) and MG132-treated Pen-2 KO (data not shown) IP
activity assays, we would expect a 5−10% level of cleavage. This
would equate to Aβ40 production in the range of 50−200 pg/mL,
which is within the detection limits of our ELISA. We therefore
suggest that PS1 heterodimer−Nct−Aph1 tripartite complexes are
either inactive or only partially active. Pen-2 binding to PS1 may
act to stabilize these complexes, allowing time for autoproteolysis
and activation to occur. The relatively less stable PS1 heterodimer
can then be held together by interactions of Pen-2 TMD1 with
PS1 TMD4, Pen-2 loop with PS1 HDVII, and Pen-2 TMD2 with
PS1-CTF.
In summary, we use systematic mutagenesis to provide
evidence that the mechanism by which Pen-2 functions in the
context of γ-secretase is multivariate, with diﬀerent regions and
even individual residues having apparently diﬀerent roles. We
also observed apparent PS1 endoproteolysis in the complete
absence of Pen-2. An improved understanding of these
mechanisms may require detailed structural information about
the nature of the Pen-2−PS1 interaction.
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